Target intelligence / Profile preview

Presynaptic cholinergic nerve terminal

Molecular classification
Other
01

Overview

The term "presynaptic cholinergic nerve terminals" refers to the structure at the end of a cholinergic neuron’s axon where acetylcholine is synthesized, stored, and released into the synaptic cleft to signal other neurons, muscles, or glands[1][3][5]. This is a cellular/anatomical site rather than a specific molecule or receptor. A presynaptic cholinergic nerve terminal is the specialized ending of a neuron that synthesizes, stores, and releases acetylcholine, the main neurotransmitter used in cholinergic signaling in both the central and peripheral nervous systems[1][3][5]. Located at synapses, especially neuromuscular junctions and central cholinergic pathways, these terminals maintain vesicles containing acetylcholine, release it upon action potential-induced calcium influx, and are central to muscle contraction, cognitive function, and autonomic control[1][3][4][5]. They express presynaptic cholinergic receptors (muscarinic and nicotinic subtypes) that regulate neurotransmitter release, but the terminal itself is not a discrete molecular entity for pharmacological targeting[2][3]. Key clarification: "Presynaptic cholinergic nerve terminal" is an anatomical region or compartment, not a molecular target such as a receptor, enzyme, or transporter. Drugs may act on proteins or receptors located in or at these terminals (e.g., acetylcholine receptors, acetylcholinesterase, vesicular acetylcholine transporter), but the terminal as a whole is not a single, well-defined therapeutic target[1][2][3][4][5]. If you need information for a specific molecular target localized at these terminals, such as "acetylcholine transporter," "vesicular acetylcholine transporter," "acetylcholinesterase," "nicotinic acetylcholine receptor (nAChR)," or "muscarinic acetylcholine receptor (mAChR)", please specify.

Other names
cholinergic nerve endingcholinergic presynaptic terminalpresynaptic cholinergic terminalcholinergic axon terminal
02

Biological functions

Neurotransmitter releaseSignal transductionSynaptic transmission
03

Disease associations

Neurodegenerative diseaseMyasthenia gravisOther

Beyond the preview

Go deeper on Presynaptic cholinergic nerve terminal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Presynaptic cholinergic nerve terminal.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call